Medical supplies contracts

4,328 open tenders

CountryTenderValueClosesDays left

Conclusion of non-exclusive discount agreements under § 130a, paragraph 8 of the German Social Code Book V (Open-House Model)

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 598669-2025

value not stated13 lots

Thu 1 Jul12:00 in Berlin

244days

Open framework agreement on drug discounts pursuant to § 130a, sub-section 8 of the German Social Security Code (SGB V), with the possibility of joining at any time, so-called approval model 2025-07

Deutsche Rentenversicherung Knappschaft-Bahn-See, BochumTED 549480-2026

value not stated9 lots

Mon 5 Jul23:59 in Berlin

248days

Successive supply of single-use medical devices (17 items) – 20/SMJU/2026

Krakowskie Pogotowie Ratunkowe, KrakówTED 448401-2026

1,605,431 zł17 lots

Fri 30 Jul10:00 in Warsaw

273days

Open House Biologics Discount Agreements 2026-21 - Golimumab

Techniker Krankenkasse, HamburgTED 389754-2026

value not stated1 lot

Sat 31 Jul23:58 in Berlin

274days

Open-House Discount Agreements 2025-07

Techniker Krankenkasse, HamburgTED 697017-2026

value not stated16 lots

Sat 31 Jul23:58 in Berlin

274days

Open House Biologics Discount Agreements 2026-24 - Aflibercept (ATC: S01LA05; Strength: 40 mg/ml)

Techniker Krankenkasse, HamburgTED 385850-2026

value not stated1 lot

Sat 31 Jul23:58 in Berlin

274days

Conclusion of non-exclusive drug discount agreements under § 130a, paragraph 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Nilotinib (WHO ATC code: L01EA03)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 308469-2026

value not stated1 lot

Sat 31 Jul23:58 in Berlin

274days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for medicinal products containing the active substance Denosumab Xgeva (WHO ATC Code: M05BX04)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 464454-2026

value not stated1 lot

Sat 31 Jul23:58 in Berlin

274days

Conclusion of non-exclusive drug discount agreements under § 130a, paragraph 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Ustekinumab (WHO ATC code: L04AC05)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 343328-2026

value not stated1 lot

Sat 31 Jul23:58 in Berlin

274days

Open House Biologics Discount Agreements 2026-22 - Ustekinumab

Techniker Krankenkasse, HamburgTED 389808-2026

value not stated1 lot

Sat 31 Jul23:58 in Berlin

274days

Pharmaceutical contracts with join option

BARMER Beschaffung und Vergabe, WuppertalTED 665604-2026

value not stated42 lots

Sun 1 Aug12:00 in Berlin

275days

Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) (Open-House model)

AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 674023-2025

value not stated3 lots

Sun 1 Aug12:00 in Berlin

275days

Open framework agreement on pharmaceutical discounts pursuant to § 130a Abs. 8 SGB V with immediate join option, so-called admission model 2025-08

Deutsche Rentenversicherung Knappschaft-Bahn-See, BochumTED 547952-2026

value not stated16 lots

Thu 5 Aug23:59 in Berlin

279days

Conclusion of non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for patent-protected active substances VV88

GWQ ServicePlus AG, DüsseldorfTED 9989-2026

value not stated2 lots

Tue 10 Aug10:00 in Berlin

284days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for patented active substances-VV90

GWQ ServicePlus AG, DüsseldorfTED 356112-2026

value not stated1 lot

Tue 10 Aug10:00 in Berlin

284days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 or § 130c para. 8 of the German Social Code V (SGB V) for patent-protected active substances-VV93

GWQ ServicePlus AG, DüsseldorfTED 575544-2026

value not stated18 lots, 2 years

Tue 10 Aug10:00 in Berlin

284days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for patented active substances-VV89

GWQ ServicePlus AG, DüsseldorfTED 142448-2026

value not stated3 lots

Tue 10 Aug10:00 in Berlin

284days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for biosimilar active substances

GWQ ServicePlus AG, DüsseldorfTED 535232-2026

value not stated4 lots

Tue 10 Aug10:00 in Berlin

284days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for patented active substances-VV90

GWQ ServicePlus AG, DüsseldorfTED 347880-2026

value not stated11 lots, 2 years

Tue 10 Aug10:00 in Berlin

284days

Open-House Drug Rebate Contracts under § 130a para. 8c SGB V for Eribulin (ATC: L01XX41) – Contract Regions Lower Saxony, Bremen and Saxony-Anhalt

AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 573935-2025

value not stated1 lot

Sat 21 Aug12:00 in Berlin

295days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.